CUE1 is a non-invasive sensory device developed by Queen Mary University of London for treating motor symptoms in Parkinson's disease. The device provides vibrotactile cues to improve gait and reduce freezing of gait.
Trial ID: NCT06174948
Sponsor: Queen Mary University of London
Status: Recruiting
Objective: Evaluate efficacy of CUE1 device for PD motor symptoms
The CUE1 device delivers rhythmic vibrotactile cues to the wrist or ankle, providing sensory feedback that helps normalize gait patterns in PD patients.